Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

10843	Companies
235442	Keywords
164365	Articles
126127	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 12/23/2025 at 14:02, 7 months 25 days ago

FDA approves another interchangeable Ranibizumab Biosimilar, Nufymco® – Strengthening US Presence with Zydus as Commercialization Partner
FDA approves Formycon's Nufymco® as interchangeable Ranibizumab Biosimilar, partnering with Zydus for commercialization in the US, expanding access to retinal therapies

FDA Approval Formycon Zydus Interchangeable Biosimilar Nufymco®
BRIEF

published on 12/09/2025 at 13:09, 8 months 8 days ago

Formycon and Zydus Forge Licensing Agreement for FYB206 in North America

Licensing Agreement Biosimilar Formycon Keytruda Zydus
BRIEF

published on 12/09/2025 at 13:09, 8 months 8 days ago

Accord de licence entre Formycon et Zydus Forge pour le FYB206 en Amérique du Nord

Formycon Biosimilaire Contrat De Licence Keytruda Zydus
PRESS RELEASE

published on 12/09/2025 at 13:04, 8 months 8 days ago

Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda® (Pembrolizumab), in the U.S. and Canada
Formycon AG and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to Keytruda (Pembrolizumab), in the U.S. and Canada. Agreement includes milestone payments, development progress, and upcoming data release

Formycon AG Biosimilar Keytruda Zydus Exclusive Licensing
BRIEF

published on 12/04/2025 at 06:35, 8 months 13 days ago

Formycon and MS Pharma Collaborate for Keytruda® Biosimilar in MENA

MS Pharma Biosimilar Agreement Keytruda® FYB206 MENA Market Formycon Partnership
BRIEF

published on 12/04/2025 at 06:35, 8 months 13 days ago

Formycon et MS Pharma collaborent pour le biosimilaire de Keytruda® au Moyen-Orient et en Afrique du Nord

MS Pharma Keytruda® FYB206 Accord Sur Les Biosimilaires Marché MENA Partenariat Formycon
PRESS RELEASE

published on 12/04/2025 at 06:30, 8 months 13 days ago

Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda® biosimilar candidate FYB206 for the MENA Region
Formycon AG and MS Pharma enter exclusive partnership to commercialize Keytruda biosimilar FYB206 in MENA region, aiming to enhance cancer drug access

MENA Region MS Pharma Biosimilar Formycon Keytruda
BRIEF

published on 11/24/2025 at 06:35, 8 months 23 days ago

Formycon Partners with NTC for Biosimilar Commercialization in Italy

Formycon AG Ophthalmology Biosimilar Partnerships Italy Pharmaceutical Market FYB203/Baiama®
BRIEF

published on 11/24/2025 at 06:35, 8 months 23 days ago

Formycon s'associe à NTC pour la commercialisation de biosimilaires en Italie

Formycon AG Ophtalmologie FYB203/Baiama® Partenariats En Matière De Biosimilaires Marché Pharmaceutique Italien
PRESS RELEASE

published on 11/24/2025 at 06:30, 8 months 23 days ago

NTC becomes commercialization partner for Formycon’s Eylea® biosimilar FYB203/Baiama® in Italy
Formycon AG partners with NTC for Eylea biosimilar commercialization in Italy. Agreement includes royalties and supply chain organization

Italy Formycon AG Commercialization Eylea Biosimilar NTC

Accesswire

Published on 08/17/2026 at 15:00, 2 hours 3 minutes ago

Norsemont Appoints Ariel Tepperman to Its Board
Published on 08/17/2026 at 14:30, 2 hours 33 minutes ago

Alset AI Completes Sale of 9.9% Interest in Lyken AI Computing to FingerMotion
Published on 08/17/2026 at 14:00, 3 hours 3 minutes ago

FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at 2026 Esports World Cup
Published on 08/17/2026 at 14:00, 3 hours 3 minutes ago

Orogen Royalties and Aurum Discovery form Generative Alliance in Norway
Published on 08/17/2026 at 13:00, 4 hours 3 minutes ago

Eagle Plains Samples up to 269g/t Au at the Pine Channel Gold Project, Saskatchewan

View all ACCESSWIRE

EQS Group

Published on 08/17/2026 at 16:05, 58 minutes ago

Mavrix Makes the Case for Trusted Human Evidence in the AI Era at Quirk's New York
Published on 08/17/2026 at 15:44, 1 hour 19 minutes ago

JOST Werke SE begins trading on OTCQX® Best Market in the United States
Published on 08/17/2026 at 15:25, 1 hour 38 minutes ago

Form 8.3 - The Vanguard Group, Inc.: AEW UK REIT plc
Published on 08/17/2026 at 15:24, 1 hour 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 08/17/2026 at 15:23, 1 hour 40 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc

Les Echos

Published on 08/17/2026 at 14:19, 2 hours 44 minutes ago

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Published on 08/17/2026 at 09:59, 7 hours 4 minutes ago

260817 BENETEAU Transaction sur actions propres
Published on 08/17/2026 at 08:33, 8 hours 30 minutes ago

Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026
Published on 08/17/2026 at 08:33, 8 hours 30 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 10 août 2026 au 11 août 2026
Published on 08/17/2026 at 07:30, 9 hours 33 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 10 au 14 août 2026

View all LES ECHOS COMFI WIRE